Table 1. Baseline characteristics and comorbid conditions in study population.
| All patients ( n = 127) | Therapeutic anticoagulation ( n = 67) | Not on therapeutic anticoagulation ( n = 60) | Significance | |
|---|---|---|---|---|
| Age in years (SD) | 74 (15) | 72 (12) | 77 (18) | 0.051 |
| Male sex | 68 (54) | 36 (54) | 32 (53) | 0.964 |
| Caucasian race | 51 (40) | 21 (31) | 30 (50) | 0.032 |
| BMI > 30 kg/m 2 | 53 (42) | 39 (58) | 14 (23) | <0.0001 |
| Diabetes | 59 (46) | 34 (51) | 25 (42) | 0.305 |
| Hypertension | 96 (76) | 52 (78) | 44 (73) | 0.575 |
| Coronary artery disease | 37 (29) | 17 (25) | 20 (33) | 0.324 |
| Heart failure | 27 (21) | 16 (24) | 11 (18) | 0.444 |
| VTE | 14 (12) | 9 (14) | 5 (9) | 0.407 |
| Atrial fibrillation | 12 (10) | 9 (14) | 3 (5) | 0.134 |
| Ischemic stroke or TIA | 19 (16) | 13 (21) | 6 (11) | 0.209 |
| AKI a on admission | 63 (50) | 27 (53) | 36 (75) | 0.022 |
| CKD grade 3 and above | 34 (27) | 15 (22) | 19 (32) | 0.238 |
| Hemodialysis-dependent | 9 (7) | 3 (4) | 6 (10) | 0.226 |
| Chronic lung disease | 29 (23) | 16 (24) | 13 (22) | 0.766 |
| Active cancer | 8 (6) | 4 (6) | 4 (7) | 0.871 |
| Ever smoker | 63 (50) | 32 (48) | 31 (52) | 0.660 |
| ICU stay | 75 (59) | 55 (82) | 20 (33) | <0.0001 |
| Corticosteroid treatment | 65 (51) | 43 (64) | 22 (37) | 0.002 |
Abbreviations: AKI, acute kidney injury; BMI, body mass index; CKD, chronic kidney disease; ICU, intensive care unit; SD, standard deviation; TIA, transient ischemic attack; VTE, venous thromboembolism.
Note: Age is presented as mean (standard deviation). Other numbers presented as n (%).
a
Defined by an elevation in serum creatinine of 0.3 mg/dL or more relative to known baseline value (data available for 99 patients).